logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Exosome Diagnostics, Inc.


USPTO Granted Patents = 20



Trademarks = 4

Forward Citations = 40

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Johan Karl Olov Skog (16 out of 24 patents)

silverMedal Mikkel Noerholm (7 out of 10 patents)

bronzeMedal Leileata M Russo (6 out of 7 patents)

4.  Robert Kitchen (6 out of 6 patents)

5.  Vasisht Tadigotla (4 out of 4 patents)

6.  Daniel Enderle (4 out of 5 patents)

7.  Wei Yu (4 out of 17 patents)

8.  Johan Skog (4 out of 5 patents)

9.  Wayne Comper (3 out of 3 patents)

10.  Dalin Chan (3 out of 3 patents)

11.  James Hurley (3 out of 3 patents)

12.  Sudipto Chakrabortty (2 out of 2 patents)

13.  Michael Valentino (2 out of 2 patents)

14.  Dominik Grimm (2 out of 2 patents)

15.  Aparna Ramachandran (2 out of 2 patents)


20 patents:

1. 12493029 - Compositions, methods, and kits for the isolation of extracellular vesicles (2025-12-09),
2. 12378608 - Methods for developing urine biomarkers and for detecting bladder cancer (2025-08-05),
3. 12312582 - Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom (2025-05-27),
4. 12258587 - Compositions and methods for internal controls of microvesicle isolations (2025-03-25),
5. 12018334 - Controls for nucleic acid assays (2024-06-25),
6. 11899024 - Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles (2024-02-13),
7. 11891664 - Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers (2024-02-06),
8. 11457899 - Apparatuses, methods, and systems for sample collection and dispersion (2022-10-04),
9. 11427864 - Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients (2022-08-30),
10. 11407991 - Nucleic acid extraction from heterogeneous biological materials (2022-08-09),
11. 11396676 - Sequencing and analysis of exosome associated nucleic acids (2022-07-26),
12. 11345957 - Methods of treating glioblastoma in a subject informed by exosomal RNA signatures (2022-05-31),
13. 11268085 - Methods for isolating microvesicles and extracting nucleic acids from biological samples (2022-03-08),
14. 11214833 - Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection (2022-01-04),
15. 11136627 - Controls for nucleic acid assays (2021-10-05),
Exosome Diagnostics, Inc. is revolutionizing liquid biopsy through their proprietary exosome technology. They utilize exosomes, small extracellular vesicles, to enable the development of non-invasive diagnostics that can detect and monitor various diseases. By harnessing the power of exosomes, Exosome Diagnostics is advancing personalized medicine and transforming patient care.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Exosome Diagnostics, Inc.
20 Patents

#71 in Waltham, MA

#981 in Massachusetts

#16,363 in US

#31,176 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Exosome Diagnostics, Inc.

Forward Citations = 40

33 inventors:

goldMedal Johan Karl Olov Skog (16 out of 24 patents)

silverMedal Mikkel Noerholm (7 out of 10 patents)

bronzeMedal Leileata M Russo (6 out of 7 patents)

4.  Robert Kitchen (6 out of 6 patents)

5.  Vasisht Tadigotla (4 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…